Athebio AG
8952 Schlieren, Wagistrasse 18
+41 44 508 08 28
hello@athebio.com
Athebio develops advanced binding molecules based on repeat proteins to help drug developers fill their pipelines with innovative drug candidates.
Athebio AG
Wagistrasse 18
8952 Schlieren
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
374 Ergebnisse für "fill" unter Somagenetix
Bulk-Fill-Komposite - Zurich Open Repository and Archive
... Copy Abstract Bulk- fill resin composites represent an innovative class of dental composite ... - fill composite materials and provides recommendations for the successful use of these materials in ... Bulk- Fill-Komposite - Zurich Open Repository and Archive ... Bulk- Fill-Komposite - Zurich Open Repository and Archive Header Quicknavigation Home Navigation ... Bulk- Fill-Komposite - Zurich Open Repository and Archive ...
Genotoxic potential of dental bulk-fill resin composites - Zurich O...
... Copy Abstract OBJECTIVE: To investigate both genotoxicity and hardening of bulk- fill composite ... flowable bulk- fill materials and one conventional flowable composite were filled in molds (height: 4mm) and ... Genotoxic potential of dental bulk- fill resin composites - Zurich Open Repository and Archive ... Genotoxic potential of dental bulk- fill resin composites - Zurich Open Repository and Archive ... Genotoxic potential of dental bulk- fill resin composites - Zurich Open Repository and Archive ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
376 Ergebnisse für "fill" unter University of Zurich
Threshold relations in subsurface stormflow: 2. The fill and spill ...
... . The fill and spill hypothesis presented in this paper is a process explanation for the observed ... connectivity was achieved compared to when connectivity was not achieved. The fill and spill hypothesis ... Threshold relations in subsurface stormflow: 2. The fill and spill hypothesis - Zurich Open ... Threshold relations in subsurface stormflow: 2. The fill and spill hypothesis - Zurich Open ... Threshold relations in subsurface stormflow: 2. The fill and spill hypothesis - Zurich Open ...
wyss-logo.svg
... image/svg+xml .st0{ fill:#FFFFFF;} .st1{ fill:#868686;} .st2{ fill:#007BC1;} .st3{ fill:#00ABE8;} ... image/svg+xml .st0{ fill:#FFFFFF;} .st1{ fill:#868686;} .st2{ fill:#007BC1;} .st3{ fill:#00ABE8;} ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
Neurimmune Therapeutics AG
8952 Schlieren, Wagistrasse 18
+41 44 755 46 46
info@neurimmune.com
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases.
Neurimmune Therapeutics AG
Wagistrasse 18
8952 Schlieren
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
ProteoMediX AG
8952 Schlieren, Wagistrasse 23
+41 44 733 40 90
contact@proteomedix.com
ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.
ProteoMediX AG
Wagistrasse 23
8952 Schlieren
9 Ergebnisse für "fill" unter ProteoMediX AG
... .st0{ fill:#3A96DB;} .st1{ fill:#FFFFFF;} .st2{ fill:#1D1D1B;} ... .st0{ fill:#3A96DB;} .st1{ fill:#FFFFFF;} .st2{ fill:#1D1D1B;} ...
NovaGo Therapeutics AG
http://www.novagotherapeutics.com
8952 Schlieren, Wagistrasse 27
NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics that promote nerve repair and regeneration in the treatment of cerebral stroke and spinal cord injury. NovaGo is developing human antibody therapeutics against Nogo-A. Nogo-A is the most potent inhibitor of nerve fiber regeneration. Anti-NogoA treatment promotes recovery of function in several animal models of stroke. Novago Therapeutics' anti-NogoA treatment represents a novel, regenerative approach for stroke. Recovery of function in stroke and other neurological disorders will be a clinical breakthrough and have a major economic impact on health care.
NovaGo Therapeutics AG
Wagistrasse 27
8952 Schlieren
Standortförderung Kanton Zürich
https://www.zh.ch/de/volkswirtschaftsdirektion/amt-fuer-wirtschaft/standortfoerderung.html
8090 Zürich, Walchestrasse 19
+41 43 259 49 92
standort@vd.zh.ch
The Division of Business and Economic Development supports resident companies, promotes Zurich's innovation capacity by way of connecting the relevant stakeholders in key industries, fosters external economic relations and offers guidance to companies interested in moving to Zurich.
Standortförderung Kanton Zürich
Walchestrasse 19
8090 Zürich
42 Ergebnisse für "fill" unter Standortförderung Kanton Zürich
FlexOffice (Schweiz) AG
https://flexoffice.swiss/location/zurich-jed/
8952 Schlieren, Zürcherstrasse 39D
+41 58 255 29 67
Where innovation meets sustainability: Zurich JED offers dynamic workspaces designed for community and collaboration. Flexible offices and nature-inspired Neighbourhoods foster creativity, focus, and connection, making work more than just a job. Located in one of Switzerland’s most sustainable buildings, FlexOffice provides all-inclusive services to simplify your workday and ensure everything is taken care of. Dedicated Location Managers are always on hand to support your needs, creating a seamless and tailored office experience.
FlexOffice (Schweiz) AG
Zürcherstrasse 39D
8952 Schlieren
36 Ergebnisse für "fill" unter FlexOffice (Schweiz) AG
